BUB revenue up 9.2% to AUD 112M; EBITDA improves
BUB revenue rose 9.2% to AUD 112M. Underlying EBITDA improved. The U.S. leads growth and an FDA approval is close.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.